---
title: "Wet AMD Market Set for Robust Growth Through 2036, Driven by Advancements in Anti-VEGF Therapies | DelveInsight"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287775165.md"
description: "The market for wet age-related macular degeneration (AMD) is forecasted to expand as the number of diagnosed cases continues to rise. This growth is further fueled by the introduction of new therapies like Ixoberogene soroparvovec (Ixo-vec) by Adverum Biotechnologies, Surabgene lomparvovec (RGX-314) by Regenxbio/AbbVie, and OGX-110. These emerging treatments are expected to contribute to the market’s upward trajectory alongside current therapies."
datetime: "2026-05-27T12:36:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287775165.md)
  - [en](https://longbridge.com/en/news/287775165.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287775165.md)
generator: "portal-rs"
---

# Wet AMD Market Set for Robust Growth Through 2036, Driven by Advancements in Anti-VEGF Therapies | DelveInsight

The market for wet age-related macular degeneration (AMD) is forecasted to expand as the number of diagnosed cases continues to rise. This growth is further fueled by the introduction of new therapies like Ixoberogene soroparvovec (Ixo-vec) by Adverum Biotechnologies, Surabgene lomparvovec (RGX-314) by Regenxbio/AbbVie, and OGX-110. These emerging treatments are expected to contribute to the market’s upward trajectory alongside current therapies.

### Related Stocks

- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [ADVM.US](https://longbridge.com/en/quote/ADVM.US.md)
- [RGNX.US](https://longbridge.com/en/quote/RGNX.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Meeder Asset Management Inc. Boosts Stake in AbbVie Inc. $ABBV](https://longbridge.com/en/news/297398087.md)
- [Northwestern Mutual Wealth Management Co. Makes New $67.61 Million Investment in AbbVie Inc. $ABBV](https://longbridge.com/en/news/297755007.md)
- [FDA places clinical hold on REGENXBIO’s RGX-121 in MPS II trial](https://longbridge.com/en/news/298029915.md)
- [AbbVie (NYSE:ABBV) Issues FY 2026 Earnings Guidance](https://longbridge.com/en/news/297966481.md)
- [Trivium Point Advisory LLC Increases Stock Holdings in AbbVie Inc. $ABBV](https://longbridge.com/en/news/297292955.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**